Literature DB >> 1638839

Metastatic malignant struma ovarii. Two case reports.

R D Thomas1, V B Batty.   

Abstract

Struma ovarii is an ovarian germ cell tumor consisting mainly of thyroid tissue. Five percent of struma ovarii are malignant, and of these only five percent metastasize. The rarity of this disease has resulted in difficulty in agreeing on treatment regimes and in limited imaging experience. The authors report two cases and highlight the imaging and monitoring difficulties encountered in their management. The authors conclude that I-131 has a role to play both therapeutically and in monitoring these patients, but that biochemical testing is a more reliable indicator of disease status.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638839     DOI: 10.1097/00003072-199207000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels.

Authors:  M Guida; V D Mandato; A Di Spiezio Sardo; C Di Carlo; E Giordano; C Nappi
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Malignant struma ovarii.

Authors:  Fevziye Kabukcuoglu; Alparslan Baksu; Banu Yilmaz; Alpay Aktumen; Ismail Evren
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

3.  Radiotherapy with iodine-131 in recurrent malignant struma ovarii.

Authors:  W Brenner; K H Bohuslavizki; H Wolf; C Sippel; M Clausen; E Henze
Journal:  Eur J Nucl Med       Date:  1996-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.